Motor Neurone Disease F035
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/motor-neurone-disease-f035-g122
Rulebase for motor neurone disease
<h5><strong>Current RMA Instruments</strong></h5><table border="1" cellpadding="0" cellspacing="1" width="100%"><tbody><tr><td><p><em><u><a href="http://www.rma.gov.au/assets/SOP/2021/e7a52d444b/111.pdf" target="_blank">Reasonable Hypothesis SOP</a></u></em></p></td><td><p>111 of 2021</p></td></tr><tr><td><p><em><u><a href="http://www.rma.gov.au/assets/SOP/2021/94f21b8754/112.pdf" target="_blank">Balance of Probabilities SOP </a></u></em></p></td><td><p>112 of 2021</p></td></tr></tbody></table><h5><strong>Changes from previous SOPs</strong></h5><p><drupal-media data-entity-type="media" data-entity-uuid="98078018-e268-43e0-841f-99df9ceed629" data-view-mode="wysiwyg"></drupal-media></p><h5><strong>ICD Coding</strong></h5><ul><li>ICD-9-CM Codes: 335.2</li><li>ICD-10-AM Codes: G12.2</li></ul><h5><strong>Brief description</strong></h5><p>This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.</p><h5><strong>Confirming the diagnosis</strong></h5><p>This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.</p><p>The relevant medical specialist is a neurologist.</p><h5><strong>Additional diagnoses covered by SOP</strong></h5><ul><li>Amyotrophic lateral sclerosis</li><li>Lou Gerhig’s disease</li><li>Motor neuron disease</li><li>Primary lateral sclerosis</li><li>Progressive bulbar palsy</li><li>Progressive spinal muscular atrophy</li></ul><h5><strong>Conditions excluded from SOP </strong></h5><ul><li>Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)</li><li>Hereditary myopathies</li><li>Inflammatory myopathy (polymyositis<span>#</span>, dermatomyositis*)</li><li>Multifocal motor neuropathy<sup>#</sup></li><li>Myasthenia gravis*</li><li>Paraneoplastic diseases</li><li>Post-polio syndrome<sup>#</sup></li></ul><p>* another SOP applies</p><p><sup>#</sup> non-SOP condition</p><h5><strong>Clinical onset</strong></h5><p>Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.</p><h5><strong>Clinical worsening</strong></h5><p>The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia. </p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/rulebase-motor-neurone-disease
Cigar smoking
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/motor-neurone-disease-f035-g122/rulebase-motor-neurone-disease/cigar-smoking
Cigarette smoking
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/motor-neurone-disease-f035-g122/rulebase-motor-neurone-disease/cigarette-smoking
Electrical injury
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/motor-neurone-disease-f035-g122/rulebase-motor-neurone-disease/electrical-injury
Inability to obtain appropriate clinical management for motor neurone disease
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/motor-neurone-disease-f035-g122/rulebase-motor-neurone-disease/inability-obtain-appropriate-clinical-management-motor-neurone-disease
Pipe smoking
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/motor-neurone-disease-f035-g122/rulebase-motor-neurone-disease/pipe-smoking
Smoking tobacco products - material contribution
Current RMA Instruments
111 of 2021 | |
112 of 2021 |
Changes from previous SOPs
ICD Coding
- ICD-9-CM Codes: 335.2
- ICD-10-AM Codes: G12.2
Brief description
This is a chronic progressive neurological disease involving the motor pathways of the body in the brain, spinal cord and peripheral nerves. This condition generally presents with both upper and lower motor neurone signs involving more than one region, i.e. cranial, cervical, thoracic, lumbosacral. Clinical signs are muscle weakness (paresis, paralysis), muscle atrophy, hyperreflexia, and spasticity.
Confirming the diagnosis
This is a complex diagnosis requiring specialist opinion, appropriate investigations (e.g. MRI scans of the brain and spinal cord, spinal puncture and electrophysiological studies of the nerves and muscles), assessment against appropriate diagnostic criteria and the exclusion of other pathologies.
The relevant medical specialist is a neurologist.
Additional diagnoses covered by SOP
- Amyotrophic lateral sclerosis
- Lou Gerhig’s disease
- Motor neuron disease
- Primary lateral sclerosis
- Progressive bulbar palsy
- Progressive spinal muscular atrophy
Conditions excluded from SOP
- Cervical radiculomyelopathy (may be covered by cervical spondylosis SOP)
- Hereditary myopathies
- Inflammatory myopathy (polymyositis#, dermatomyositis*)
- Multifocal motor neuropathy#
- Myasthenia gravis*
- Paraneoplastic diseases
- Post-polio syndrome#
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will be based on when progressive symptoms consistent with motor neuron dysfunction first appeared.
Clinical worsening
The normal course for the condition would be for it to progress at a steady rate, leading to death after a median time of approximately three to five years. The only SOP worsening factor is for inability to obtain appropriate clinical management. Disease modifying treatment that slightly slows disease progression and prolongs life in some patients is available in Australia.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/motor-neurone-disease-f035-g122/rulebase-motor-neurone-disease/smoking-tobacco-products-material-contribution